# K222533: Target Tetra Detachable Coils

- Pathway: 510(k) (Traditional)
- Applicant: Stryker Neurovascular
- Decided: Dec 14, 2022 after 114 days
- Product code: HCG (Device, Neurovascular Embolization)
- Device class: 2
- Regulation: 21 CFR 882.5950
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 14 generations back to K951256 (1995). 40 ancestors in all.
3 later devices descend from it; 1 cites it directly.
0 of 44 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K153658: Target Detachable Coils, Stryker Neurovascular (2016) Summary page 4.
- K161429: Target Detachable Coils, Stryker Neurovascular (2016) Summary page 4.

## Most influential descendants
- K242243: Target Detachable Coils (2024), 2 descendants of its own
- K252694: Target Detachable Coil (2025), 1 descendant of its own
- K261772: Target Xtra Detachable Coil (2026), 0 descendants of its own

## Indications for use
Target Detachable Coils are intended to endovascularly obstruct or occlude blood flow in vascular abnormalities of the neurovascular and peripheral vessels. Target Detachable Coils are indicated for endovascular embolization of: • Intracranial aneurysms • Other neurovascular abnormalities such as arteriovenous malformations and arteriovenous fistulae • Arterial and venous embolizations in the peripheral vasculature

Source page: https://510kreport.com/device/K222533
Methodology: https://510kreport.com/methodology